/Investor DB

eGenesis, Inc. Full-time

operating company · company profile

New York · 2 people tracked

Find your way into eGenesis, Inc. Full-time

Sign up to see every warm intro you have to eGenesis, Inc. Full-time

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the eGenesis, Inc. Full-time team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

eGenesis addresses organ transplant scarcity through cross-species transplantation enabled by advanced genome engineering. The firm has built a porcine platform with targeted genetic edits to mitigate retroviral risk and achieve immunologic and molecular compatibility with human recipients, aiming to eliminate transplant waitlists and reduce mortality.

Source: firm website, verified Aug 6, 2026.

HQ
New York, NY, US

Team · 2 people

from the firm's website & public directories

Frequently asked questions

What sectors does eGenesis, Inc. Full-time focus on?
eGenesis, Inc. Full-time focuses on Biotech, Deep Tech, Medical Devices.
Where is eGenesis, Inc. Full-time located?
eGenesis, Inc. Full-time is headquartered in New York, US.

Images

eGenesis, Inc. Full-time photo

Similar investors